Kiniksa Pharmaceuticals International, plc·4

Apr 30, 6:33 PM ET

Patel Sanj K 4

4 · Kiniksa Pharmaceuticals International, plc · Filed Apr 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Kiniksa (KNSA) CEO Sanj K. Patel Exercises Options, Sells 508,339 Shares

What Happened

  • Sanj K. Patel, Chairman & CEO of Kiniksa Pharmaceuticals (KNSA), exercised optioned shares and sold the resulting shares across April 28–30, 2026. He exercised a total of 508,339 shares (multiple option tranches) by paying roughly $6.84M and sold the 508,339 shares in multiple block trades for total proceeds of about $26.42M. The net cash from these transactions is approximately $19.58M. The filing shows option exercises (transaction code M) immediately followed by open-market sales (transaction code S).

Key Details

  • Dates: Transactions reported for 2026-04-28 through 2026-04-30; Form 4 filed 2026-04-30.
  • Exercises (paid): 508,339 shares total — examples: 431,904 @ $10.36 ($4,474,525) and 51,750 + 22,544 + 2,141 @ $30.93 (total $2,364,135); total exercise cost ≈ $6,838,660.
  • Sales (proceeds): 508,339 shares total sold in multiple trades — aggregated proceeds ≈ $26,415,227 (per-line weighted averages shown in filing).
  • Net proceeds: ≈ $19,576,567 (proceeds minus exercise cost).
  • Footnotes: Filing notes at least some transactions were effected pursuant to a 10b5-1 plan executed Oct 31, 2025. Sales were executed in multiple trades at the price ranges reported (per footnotes). The options exercised were fully vested (per filing).
  • Shares owned after transaction: not specified in the materials provided in this summary (refer to the Form 4 for the reported post-transaction holdings).
  • Transaction codes: M = option exercise/conversion; S = open-market sale.

Context

  • The pattern—exercising vested options and immediately selling the resulting shares—functions like a cashless exercise (exercise then sale) and is commonly used to cover exercise cost/taxes or monetize vested equity. This filing is factual reporting of those actions; it does not state the insider’s motives.

Insider Transaction Report

Form 4
Period: 2026-04-28
Patel Sanj K
DirectorCHAIRMAN & CEO
Transactions
  • Exercise/Conversion

    Class A Ordinary Share

    [F1]
    2026-04-28$10.36/sh+431,904$4,474,525431,904 total
  • Exercise/Conversion

    Class A Ordinary Share

    [F1]
    2026-04-28$30.93/sh+51,750$1,600,628483,654 total
  • Sale

    Class A Ordinary Share

    [F1][F2]
    2026-04-28$50.43/sh74,635$3,763,843409,019 total
  • Sale

    Class A Ordinary Share

    [F1][F3]
    2026-04-28$51.47/sh113,673$5,850,749295,346 total
  • Sale

    Class A Ordinary Share

    [F1][F4]
    2026-04-28$52.02/sh243,596$12,671,86451,750 total
  • Sale

    Class A Ordinary Share

    [F1][F5]
    2026-04-28$54.02/sh51,750$2,795,5350 total
  • Exercise/Conversion

    Class A Ordinary Share

    [F1]
    2026-04-29$30.93/sh+22,544$697,28622,544 total
  • Sale

    Class A Ordinary Share

    [F1][F6]
    2026-04-29$54.01/sh22,544$1,217,6010 total
  • Exercise/Conversion

    Class A Ordinary Share

    [F1]
    2026-04-30$30.93/sh+2,141$66,2212,141 total
  • Sale

    Class A Ordinary Share

    [F1][F7]
    2026-04-30$54.01/sh2,141$115,6350 total
  • Exercise/Conversion

    Share Option

    [F1][F8]
    2026-04-28431,9040 total
    Exercise: $10.36Exp: 2028-02-29Class A Ordinary Share (431,904 underlying)
  • Exercise/Conversion

    Share Option

    [F1][F8]
    2026-04-2851,75073,250 total
    Exercise: $30.93Exp: 2028-09-19Class A Ordinary Share (51,750 underlying)
  • Exercise/Conversion

    Share Option

    [F1][F8]
    2026-04-2922,54450,706 total
    Exercise: $30.93Exp: 2028-09-19Class A Ordinary Share (22,544 underlying)
  • Exercise/Conversion

    Share Option

    [F1][F8]
    2026-04-302,14148,565 total
    Exercise: $30.93Exp: 2028-09-19Class A Ordinary Share (2,141 underlying)
Holdings
  • Class A Ordinary Share

    (indirect: By Trust)
    76,174
  • Class A Ordinary Share

    (indirect: By Trust)
    109,795
  • Class A Ordinary Share

    (indirect: By Trust)
    51,794
Footnotes (8)
  • [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.985. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $51.00 and $51.99. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $52.00 and $52.58. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F5]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.22. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F6]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.225. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F7]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
  • [F8]The option is fully vested and exercisable.
Signature
/s/ Douglas Barry, Attorney-in-Fact|2026-04-30

Documents

1 file
  • 4
    form4-04302026_100400.xmlPrimary